Spain – Refuse collection services – Contratación del servicio de recogida, gestión y eliminación de los residuos generados en Hospitales de Día y Centros Asistenciales de FREMAP, Mutua Colaboradora con la Seguridad Social nº61, sitos en varias Comunidades Autónomas de España

Spain – Office cleaning services – Servicio de limpieza de las dependencias e instalaciones de la Dirección Provincial del Instituto Social de la Marina en Valencia y de sus Direcciones Locales en Gandia y Cullera b) Servicio de desinfeccion, desratizacion, desinsectacion y control de plagas en las Direcciones Locales de Gandia y Cullera c) Servicio de lavandería del vestuario profesional del Servicio de Sanidad Maritima .

Spain – Building-cleaning services – Servicio de limpieza de los Centros de Valoración de Personas con Discapacidad de Gijón y Avilés

Spain – Building-cleaning services – Servicio de limpieza de los edificios y dependencias municipales

Expected Outcome: Successful proposals will contribute to the Chemicals Strategy for Sustainability and Ecodesign for Sustainable Products Regulation, the Chemical Industry Action Plan, the Clean Industrial Deal as well as the Horizon Europe Mission "Restore our Ocean and Waters by 2030" in particular to Objective 2: "Prevent and eliminate pollution of our oceans, Seas and waters". Projects results are expected to contribute to the following expected outcomes: Full industrial scale biorefinery and related value chain(s) to produce SSbD bio-based solutions for home and/or personal care sector with significantly improved sustainability. Wider availability of bio-based products in home and/or personal care sector meeting both regulatory standards and technical performance requirements. Increased consumer/end user acceptance of bio-based solutions, facilitating market uptake. Contribution to the EU strategic autonomy, resilience and competitiveness, reducing the fossil feedstock dependence for chemicals production and minimising biomass imports dependencies. Scope: The home and personal care sector, including fast-moving consumer goods (FMCG) and cosmetics, is a key industry where…

Expected Outcome: Successful proposals will contribute to the implementation of the Zero Pollution Action Plan, the Circular Economy Action Plan, the Ecodesign for Sustainable Products Regulation, the Chemicals Strategy for Sustainability and the Chemical Industry Action Plan. They will provide solutions in line with the objectives of the EU legislation on waste but also the Horizon Europe Mission "Restore our Ocean and Waters by 2030" in particular to Objective 2: "Prevent and eliminate pollution of our oceans, Seas and waters” as well as the Horizon Europe Mission “A Soil Deal for Europe”, in particular objectives “Reduce soil pollution and enhance restoration”. Projects results are expected to contribute to the following expected outcomes: Wider availability of bio-based additives targeting high functional properties, stability and compatibility with polymers/matrices. Contribution to improved circularity of end products in relevant market sectors. Potential replicability into other industrial sectors to widen market opportunity. Reduction or avoidance of environmental impacts related to life cycle of additives and additive-containing materials and/or products. Scope: While…

Expected Outcome: In support to the implementation of the EU Adaptation Strategy, the EU Mission on Adaptation to Climate change, and in particular having regard to the upcoming European Climate Adaptation Plan, project results should contribute to all of the following expected outcomes: Local climate adaptation actors, the financing sector, the public grant sector, and climate adaptation financing experience are brought to work together on making local adaptation actions financeable by combining public grant funding and private financing via bank loans and on overcoming the practical barriers on combining these and finding solutions, and specifically through demonstrating this with intermediated EIB adaptation lending. Local innovative adaptation actions (including nature-based solutions) have been implemented thanks to their financing by the combination of private financing via bank loans and public grant funding. National Promotional Banks (NPBs)/other banks are mobilised to actively finance local adaptation actions. Scope: Rationale Financing of local adaptation actions, especially with other means than public grant funding, is currently still not taking place sufficiently.…

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this NOFO, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients' benefit. These practical goals contrast with the goals of many mechanistic, NCI-supported R01 projects that employ mammals, or develop and use mammalian cancer models, transplantation tumor models, or models derived from mammalian or human tissues or cells for hypothesis-testing, non-clinical research. Among many other possible endeavors, applicants in response to this FOA could propose demonstrations of how to overcome translational deficiencies of mammalian oncology models, define new uses of mammalian models or their genetics for unexplored translational challenges, advance standard practices for use of translational models, test approaches to validate and credential models, or challenge current practices for how models are used translationally

Apply for funding to run a high throughput screen (HTS) using AstraZeneca’s compound library and screening robots. There are two funding opportunities per year that are open to all targets.